Derrell D. Porter, MD

Chief Executive Officer and Founder

Derrell D. Porter, MD is a physician-entrepreneur with years of experience in the business of medicine, and one of the few experts with dual capabilities in developing and commercializing rapidly evolving cell therapies. Prior to establishing his first startup, Cellevolve, Dr. Porter was the Head of Commercial at Atara Bio, a leader in off-the-shelf T-cell immunotherapy. Dr. Porter has held roles of increasing responsibility at three leading biopharmaceutical companies: Gilead, AbbVie and Amgen. He started his career at McKinsey & Company. Dr. Porter earned his MD from University of Pennsylvania’s Perelman School of Medicine, where he was a Gamble Scholar, and an MBA from The Wharton School. He earned his Bachelor of Science in Neuroscience from the University of California, Los Angeles (UCLA). Additionally, he is on the boards of Passage Bio (NASDAQ: PASG), a Philadelphia-based genetics medicine company and Portal Innovations, a Chicago-based, venture development engine. Dr. Porter also serves as an Advisory Committee Member for the Penn School of Medicine. 

Outside of the office, Derrell enjoys spending time with his family, non-fiction reading, Pac-12 sports, traveling the world, and road cycling.